Navigation Links
Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
Date:10/11/2007

SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will release its third quarter 2007 financial results on Tuesday, October 30, 2007 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call at 4:30 p.m. ET hosted by Henry L. Nordhoff, chairman, president and chief executive officer, and Herm Rosenman, senior vice president, finance, and chief financial officer.

The conference call will be webcast live and may be accessed on the investment information section of the Company's web site at http://www.gen-probe.com. An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 800-947-6450 (U.S.) or 203- 369-3539. (international).

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 24 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives,
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 LifeNet Health plans to enlarge ... 2015 to more than 160 people. The ... LifeNet Health,s innovative bio-implants, which are being made more ... be served. It also is a reflection of the ... "The growth and success of LifeNet Health is a ...
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
(Date:5/29/2015)... , May 29, 2015 Educating the ... the Association for the Advancement of Wound Care ... With support from AAWC,s corporate partners, the Association ... on the AAWC website at http://aawconline.org/education-for-the-generalist/ ... care pathway with links to various CME/CEU educational ...
Breaking Medicine Technology:LifeNet Health to add more than 160 jobs in 2015 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5The Association for the Advancement of Wound Care Educates the Public 2
... Findings from an international Phase 3 clinical trial of the ... and effective at restoring continence when worn up to 12 ... 87% of users rated the ability of the device to ... study results published in the British Journal of Nursing ...
... HONG KONG, Sept. 28, 2011 /PRNewswire-Asia-FirstCall/ -- Golden ... - 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, today ... ownership in its NYSE-listed affiliate, China Cord Blood Corporation ... result of which the Group now owns 40.9% of ...
Cached Medicine Technology:Vitala™ Pouchless Continence Control Device Shown to be Safe and Effective for up to 12 Hours in Phase 3 Clinical Trial 2Vitala™ Pouchless Continence Control Device Shown to be Safe and Effective for up to 12 Hours in Phase 3 Clinical Trial 3Golden Meditech Increase Stake in NYSE-listed Affiliate - China Cord Blood Corporation to 40.9% 2
(Date:5/30/2015)... the Snail ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... Interactive mobile games for children have become quite popular these ... playing are doing much for their intellectual development. However, there’s ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a ... hanging signs ; making what was formerly an elite ... ceiling rigging points at a usual height of 16’-20’ are ... These signs are very unique and more visible than the ... and dismantle labor and rigging the costs far outweigh the ...
(Date:5/29/2015)... What does community do? , According to ... together to plant gardens, to teach young people, to ... critical issues. Community invites everyone to help improve lives ... Community Does" was commissioned by The Denver Foundation, the ... during the foundation’s Annual Celebration in May. At just ...
(Date:5/29/2015)... Cincinnati, Ohio (PRWEB) May 29, 2015 ... Proven Experience to Cincinnati , The Department of Veterans ... John A. Gennaro as the new director of the ... of health care to more than 43,000 unique Veterans ... , With over 2,000 staff, CVAMC is a two-division ...
(Date:5/29/2015)... May 29, 2015 Dot Hill can mark one ... resident of Lake Prince Woods retirement community is the ... Virginia Beach, Virginia. , “It was great fun!”, she exclaimed. ... didn’t want me to so they thought this would be ok.” ... into a vertical wind tunnel,” she described. “I don’t remember ...
Breaking Medicine News(10 mins):Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Indoor Skydiving Brings Thrills to Seniors 2
... Research shows canines can count, learn words , MONDAY, ... the beloved family dog is really a toddler with ... developmental abilities equivalent to a human 2-year-old," said dog ... canine research developments at the American Psychological Association annual ...
... , The National Comprehensive Cancer Network (NCCN) recently ... the results of the recent ERSPC trial that assessed the ... screening does save lives when performed intelligently in men at ... FORT WASHINGTON, Pa., Aug. 10 Prostate-Specific Antigen (PSA) ...
... AlphaRx Inc. (OTC BB:ALRX.OB - News), an emerging ... develop novel formulations of drugs, is pleased to ... patent in China for its topical platform technology ... The platform is an integral part of the ...
... , , NEW YORK, ... CRE ) ("Care" or the "Company"), a real estate investment and finance ... today reported financial results for the second quarter ended June 30, 2009. ... GAAP of $0.5 million, or $0.03 per basic and diluted share. ...
... ROCHESTER, N.Y., Aug. 10 Your sleeping problems might be ... (FM), and Chronic Fatigue Syndrome (CFS). But it can also be ... , , Recent studies show that chronic infection ... by Professor Mark Opp from the University of Michigan Medical School ...
... Aug. 10 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: ... Western,healthcare products and services in the People,s Republic of ... exclusive, multi-year distribution,agreements for China with Biotest AG and ... based in Dreieich, Germany (SDAX: BIO3), specializes in,innovative hematology ...
Cached Medicine News:Health News:Dogs and 2-Year-Olds on Same Mental Plane 2Health News:Dogs and 2-Year-Olds on Same Mental Plane 3Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 2Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 3Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 4Health News:NCCN Stresses Importance of PSA Testing in High-Risk Men 5Health News:AlphaRx Receives China Patent on Its Drug Delivery Platform 2Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 2Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 3Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 4Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 5Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 6Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 7Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 8Health News:Care Investment Trust Inc. Announces Second Quarter 2009 Results 9Health News:Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement 2Health News:Surprise! Better Sleep with Gene-Eden(R), an Antiviral Supplement 3Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 2Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 3Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 4
Papavero-caspar specula for trans-sphenoidal hypophysectomy....
Landolt hypophysectomie instrument, spoon, bayonet-shaped, flexible....
Fahlbusch hypophysectomie instrument, spoon, bayonet-shaped, malleable....
Cushing pituitary scoop, malleable, silver-plated....
Medicine Products: